Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to 0.2%.

  • Apyx Medical's Return on Capital Employed rose 2000.0% to 0.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2%, marking a year-over-year increase of 2000.0%. This contributed to the annual value of 0.31% for FY2024, which is 200.0% up from last year.
  • As of Q3 2025, Apyx Medical's Return on Capital Employed stood at 0.2%, which was up 2000.0% from 0.25% recorded in Q2 2025.
  • In the past 5 years, Apyx Medical's Return on Capital Employed registered a high of 0.2% during Q3 2025, and its lowest value of 0.65% during Q1 2023.
  • For the 5-year period, Apyx Medical's Return on Capital Employed averaged around 0.35%, with its median value being 0.3% (2023).
  • As far as peak fluctuations go, Apyx Medical's Return on Capital Employed plummeted by -3600bps in 2023, and later soared by 3700bps in 2024.
  • Quarter analysis of 5 years shows Apyx Medical's Return on Capital Employed stood at 0.26% in 2021, then tumbled by -115bps to 0.57% in 2022, then skyrocketed by 46bps to 0.3% in 2023, then dropped by -19bps to 0.36% in 2024, then surged by 44bps to 0.2% in 2025.
  • Its Return on Capital Employed stands at 0.2% for Q3 2025, versus 0.25% for Q2 2025 and 0.29% for Q1 2025.